QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 psyched-fda-warning-deas-telehealth-extension-ca-govs-veto-congress-on-kratom-mas--more

Cybin And Small Pharma Shareholders Green Light Acquisition Resolution

 mydecine-releases-q2-2023-developer-of-smoke-cessation-psilocybin-prodrugs--mdma-analogs

Novel psychedelic-based drugs biotech Mydecine Innovations Group (OTC: MYCOF) shared its financial results for the six months e...

 mydecines-prospectus-supplement-closing-under-share-subscription-and-management-update

Colorado-based next-generation psychedelics biotech Mydecine Innovations Group Inc. (OTC: MYCOF) announced that, in connection ...

 psyched-new-psilocybin-forms-lsd-anxiety-study-uks-parliamentary-debate-and-more

Biotech Company Discovers What May Be The First New Compounds Of Psilocybin In History NY-based biotech platform Terran Biosci...

 mydecines-q1-2023-reports-shows-decline-in-assets-and-rd-increase-in-net-loss-and-accumulated-deficit

Psychedelics biotech Mydecine Innovations Group (OTC: MYCOF) shared its condensed interim (unaudited) financial results for thr...

 new-set-of-mdma-analogs-to-hit-the-clinic-these-are-the-latest-positive-findings

Psychedelics biotech Mydecine Innovations Group (OTC: MYCOF) is advancing the development of its novel compounds family of next...

 psyched-first-ayahuasca-pill-created-psychedelics-legalization-predicted-uks-research-support-and-more

Ayahuasca Pill Is Officially Here, Filament CEO Discusses Future Plans The first medical-grade drug candidate of the psychedel...

 psychedelic-company-sale-mydecine-gets-over-25m-for-wholly-owned-tech-subsidiary-business

Mydecine Innovations Group Inc.

 psyched-musks-empathy-tweets-psychedelics-in-congress-oregons-opt-outs-maps-mdma-trial-and-more

Elon Musk Joins Twitter Conversation Around Psychedelics: A Debate On Empathy

 psychedelics-biotechs-clearmind-and-mydecine-share-consolidation-and-subscription-agreements

In connection with recent stock splits, psychedelics biotech Clearmind Medicine Inc.

 world-class-leaders-in-psychedelics-form-benzingas-psychedelic-advisory-councilget-to-know-them

The Benzinga Psychedelics Advisory Council was introduced in March of 2022 with the sustained goal of better informing investor...

Core News & Articles

https://www.globenewswire.com/news-release/2022/08/19/2501703/0/en/Mydecine-Innovations-Group-Announces-Private-Placement-Inter...

 mydecine-innovations-group-reports-q2-financial-results-and-management-updates

After the resignation of several key board members on August 12, Mydecine Innovations Group (OTC: MYCOF) reported its financial...

 understanding-the-psilocybin-supply-chain-every-production-method-explained

Psilocybin is known as the active compound in so-called “magic mushrooms”, yet most psilocybin used in clinical trials today is...

 two-psychedelic-companies-file-patent-applications-for-psilocybin-and-mdma-analogues-heres-what-could-change

Mydecine (OTC: MYCOF) and Lobe Sciences (OTCQB: LOBEF), two companies in the psychedelics space, have filed patent applications.

 government-funded-smoking-cessation-trial-uses-mydecines-new-psilocybin-derived-myco-001-recently-fda-approved

Biotech company Mydecine Innovations Group (OTC: MYCOF) received FDA approval for their novel proprietary MYCO-001. This is the...

 mydecine-announces-1-for-50-reverse-stock-split

The board of directors of Mydecine Innovations Group Inc. (OTCPK:MYCOF) voted in favor of completing a reverse stock split. Wit...

 psyched-atai-mindmed-enveric-and-mydecine-release-2021-earnings-bienstar-expands-to-brazil--more

It’s earnings week in the psychedelics space, opening a new window into the financial situations of many companies in the sector.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION